mitoxantrone has been researched along with Lassitude in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighteen women with metastatic breast cancer entered a phase I-II study of high-dose mitoxantrone (MXT)." | 7.67 | High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial. ( Leiby, JM; Neidhart, JA; Unverfurth, DV, 1986) |
| "One hundred nine patients with nonmetastatic breast carcinoma, recruited between May 1995 and February 1997, were included in a protocol combining chemotherapy with mitoxantrone and cyclophosphamide, administered intravenously in 4 cycles of 21 days, and concomitant radiotherapy." | 5.09 | Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization. ( Bouscary, ML; Camerlo, J; Genre, D; Gravis, G; Macquart-Moulin, G; Maraninchi, D; Moatti, JP; Resbeut, M; Viens, P, 1999) |
| "Eighteen women with metastatic breast cancer entered a phase I-II study of high-dose mitoxantrone (MXT)." | 3.67 | High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial. ( Leiby, JM; Neidhart, JA; Unverfurth, DV, 1986) |
| "Interventions for fatigue have not been studied, although evidence in the adult MS literature suggests possible benefit of exercise and modafinil." | 2.48 | Management of children with multiple sclerosis. ( Yeh, EA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeh, EA | 1 |
| Lebrun, C | 1 |
| Alchaar, H | 1 |
| Candito, M | 1 |
| Bourg, V | 1 |
| Chatel, M | 1 |
| Macquart-Moulin, G | 1 |
| Viens, P | 1 |
| Genre, D | 1 |
| Bouscary, ML | 1 |
| Resbeut, M | 1 |
| Gravis, G | 1 |
| Camerlo, J | 1 |
| Maraninchi, D | 1 |
| Moatti, JP | 1 |
| Bagert, B | 1 |
| Camplair, P | 1 |
| Bourdette, D | 1 |
| Leiby, JM | 1 |
| Unverfurth, DV | 1 |
| Neidhart, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised, Double Blinded Cross-over Study Comparing the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis[NCT01149525] | Phase 3 | 59 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for mitoxantrone and Lassitude
| Article | Year |
|---|---|
Management of children with multiple sclerosis.
Topics: Age of Onset; Antibodies, Monoclonal, Humanized; Child; Cyclophosphamide; Fatigue; Glatiramer Acetat | 2012 |
Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.
Topics: Adjuvants, Immunologic; Brain; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Di | 2002 |
2 trials available for mitoxantrone and Lassitude
| Article | Year |
|---|---|
Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue.
Topics: Acetylcarnitine; Adolescent; Adult; Cyclophosphamide; Fatigue; Female; Humans; Immunosuppressive Age | 2006 |
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.
Topics: Activities of Daily Living; Adult; Antineoplastic Combined Chemotherapy Protocols; Appetite; Breast | 1999 |
1 other study available for mitoxantrone and Lassitude
| Article | Year |
|---|---|
High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Dr | 1986 |